8:00 am – 8:30 am Welcome – Introductions – Opening Remarks
Moderator: Mary Beth Lang, RPH, MPM, SCD, Vice President, HC Pharmacy and SCM Commercial Services, UPMC
8:30 am -- 9:30 am Let Us Help: Working With the C-Suite on Revenue Cycle Issues
Presenter: Curt Passafume, System Vice-President for Pharmacy Services, OhioHealth
As health systems seek new sources of revenue and means for improving performance under value-based payment, some are turning to an unlikely source: their own pharmacies. Pharmacy has been relegated to simply dispensing drugs from the basement. It needs to find its way upstairs, unleashing its ability to manage chronic disease, reduce readmissions through rigorous medication reconciliation while a patient is in the hospital and be a team member that helps keep patients from returning to the hospital.
Drug price hyperinflation has hit the U.S., with annual price increases of 20% or more. If for no other reason, pharmacy needs to help slow spending on drugs. Some
steps IDNs can take to reduce drug spend:
• Finding clinical alternatives to overpriced drugs
• Conducting a literature review for optimization
• Centralizing inventory control
• Refining formularies to have fewer alternatives in each drug class
• Using contracting to leverage better prices
1. Demonstrate how pharmacy can help manage patient populations, especially through medication reconciliation.
2. Evaluate ways that pharmacists can help reduce costly readmissions.
3. Outline how drug price hyperinflation is harming IDNs’ bottom line, and what to do about it.
9:30 am -- 9:45 am Break
9:45 am – 10:45 am Demand Planning/Forecasting
Presenters: David Twitchell, PharmD, MBA, Co-Founder and President, Trellis Rx and Tony Zappa, PharmD, MBA,
Chief Solutions Officer, Trellis Rx
No more five-year plans! As IDNs grow in size and complexity, and the demands of payers and patients shift, planning for the next year becomes hard enough! Pharmacy is also reaching beyond hospital walls into the community through physician offices, satellite clinics, stand-alone ERs and so on. Planning for how to supply drugs for such a network hinges on a provider’s willingness to invest in some form of data analytics, and, just as importantly, act on those findings. A widespread absence of information technology systems that support and track interventions adds to the challenges care providers face.
- Demonstrate how to use forecasted demand to lower inpatient utilization.
- Formulate methods of using in-house analytics at similar cost and quality to that provided by third-party vendors.
- Compare and contrast the key performance indicators that really matter.
10:45 am – 11:00 am Break
11:00 am – 12:00 pm Benchmarking
Presenter: Chris Little, PharmD, BCPS, Executive Director, Clinical Sourcing, ROi
Providers need information tools to help benchmark pharmacy performance by hospital and medical group and against nationwide averages. Many vendors provide such tools, which include dashboards that track a range of metrics such as drug expenditures per adjusted inpatient day and antibiotic utilization by drug and clinical application. Systems also provide clinical decision support materials to validate purchasing changes and discussions in pharmacy and therapeutics meetings.
- Evaluate methods of promulgating benchmarked pharmacy data throughout the health system to get people’s attention.
- Analyze how benchmarks help reduce the number of drugs per category to lower our drug spend.
- Identify key performance indicators we should be focused on that we are not today.
All information is subject to change. Last updated 08/30/17.